metabolic
Prediabetes and GLP-1 Medications
Prediabetes (HbA1c 5.7-6.4%) affects 88 million Americans and often progresses to type 2 diabetes. GLP-1 medications can prevent or delay this progression.
60-80%
Progression prevention
0.5-1.0%
HbA1c reduction
3-6 months
Time to normalization
Prevention Benefits
GLP-1 medications are highly effective at preventing progression from prediabetes to type 2 diabetes. They improve insulin sensitivity and beta-cell function. Weight loss of 7-10% often normalizes blood glucose. They reduce post-meal blood sugar spikes that drive progression. Studies show GLP-1s can achieve diabetes remission in early-stage patients. For high-risk prediabetics, GLP-1s offer more potent protection than metformin alone.
Monitoring Progress
Baseline HbA1c and fasting glucose establish starting point. Repeat testing at 3 months shows early improvement. Many patients achieve normal glucose within 6 months. Continue monitoring even after normalization to catch any recurrence. SeraVia Energy+ Boost supports metabolic health during the transition.
Medications commonly used
Find providers who understand prediabetes
Compare GLP-1 providers by clinical oversight, medication options, pricing, and local availability.